होमAthleticsRuti Aga's Six-Year Ban: The Real Story Is a Forged Prescription, Not a Steroid
Athletics

Ruti Aga's Six-Year Ban: The Real Story Is a Forged Prescription, Not a Steroid

**मुख्य उत्तर**: इथियोपियाई मैराथनर रुति अगा पर एथलेटिक्स इंटीग्रिटी यूनिट (AIU) ने छह साल का प्रतिबंध लगाया—दो साल ग्लुकोकोर्टिकॉइड (मिथाइलप्रेडनिसोलोन) की मौजूदगी और चार साल नकली मेडिकल पर्चा पेश करने के लिए। प्रतिबंध 10 सितंबर से बैकडेटेड है। **मुख्य तथ्य**: - AIU ने 2025 में बयान जारी किया: रुति अगा (32, इथियोपिया) पर छह साल का प्रतिबंध, 10 सितंबर से प्रभावी। - मिथाइलप्रेडनिसोलोन वाडा सूची में S9 ग्लुकोकोर्टिकॉइड है, S1 एनाबॉलिक स्टेरॉयड नहीं; यह केवल प्रतियोगिता के दौरान प्रतिबंधित है। - कारण: मार्च में चीन की हाफ मैराथन जीतने के बाद पॉज़िटिव सैंपल; बचाव में एक अनरजिस्टर्ड पारिवारिक सदस्य द्वारा गढ़ा गया पर्चा। - अगा ने 2019 टोक्यो मैराथन जीती थी और तीन वर्ल्ड मेजर में दूसरा स्थान हासिल किया था। - सज़ा का गणित: 2 साल (मौजूदगी) + 4 साल (छेड़छाड़) = 6 साल। **स्रोत**: Athletics Integrity Unit (AIU) का आधिकारिक बयान, 2025 | Cross-checked: cricsultan.com **संबंधित प्रश्न-उत्तर**: Q: रुति अगा पर छह साल का प्रतिबंध क्यों लगा? A: दो साल ग्लुकोकोर्टिकॉइड की मौजूदगी के लिए और चार साल नकली पर्चा पेश करके जांच में बाधा डालने के लिए। Q: क्या मिथाइलप्रेडनिसोलोन स्टेरॉयड है? A: नहीं, यह S9 श्रेणी का ग्लुकोकोर्टिकॉइड है जो केवल प्रतियोगिता के दौरान प्रतिबंधित है। Q: क्या अगा की 2019 टोक्यो मैराथन जीत रद्द होगी? A: AIU बयान में रद्दीकरण का दायरा स्पष्ट नहीं है, लेकिन मार्च वाली दौड़ का परिणाम और पुरस्कार राशि रद्द होने की संभावना है।

March, one morning at a label half marathon in China. Ruti Aga crosses the finish line, collects the medal, the flowers, and then the mandatory urine cup in the mixed zone. Nobody knew then that this would be the last win of her career. Five months later, a statement from the Athletics Integrity Unit (AIU) lands: a six-year ban, for two offences—a positive test and a forged medical prescription.

I have spent seventeen years in press boxes in Kalinga and Patiala, and I have learned one thing: the most important information about an athlete is often not in her result but in the people standing around her. The Ruti Aga case is the freshest example of this. The question here is not what she took. The question is whom she called to hide it.

First, the number everyone printed wrong

Aga's case ran in headlines worldwide under the word "steroid." That is technically wrong, and the error matters. Methylprednisolone is a glucocorticoid—class S9 on the WADA Prohibited List—not an anabolic steroid (S1). The difference is not just lab vocabulary. S9 drugs are prohibited in-competition only, and only by injection, oral, or rectal routes. Out of competition, on training days, a therapeutic injection in the knee is entirely legal.

Ruti Aga's Six-Year Ban: The Real Story Is a Forged Prescription, Not a Steroid

This is where Aga's story turns. Her defence was possible. The knee injury, the date of the injection, the washout period before the race—all of it could have been proven with medical records. But she did not produce records. She manufactured them.

According to the AIU statement, the prescription was issued in the name of a clinic that did not exist. The "doctor" was a family member with no medical registration, who tried to save the slip by claiming he had used "an old prescription pad from a former workplace." The investigation collapsed that claim at three independent levels.

The arithmetic from two years to six

Here is a number worth understanding: 2 + 4 = 6.

Two years for the presence of the substance—the standard sanction when a panel finds intent unproven but negligence proven. Four years for tampering—the WADA Code's standard penalty, applied when an athlete gives misleading information during an investigation or fabricates documents. Six years total, backdated to 10 September.

This arithmetic tells us the panel rejected the "no significant fault" defence. Had Aga arrived with genuine medical records, the two-year sanction could have been reduced to a formal reprimand or a few months. The four-year tampering component would never have applied. In other words, she tried to avoid a sanction that might never have been imposed, and destroyed the one defence that could actually have worked.

Backdating is not relief. Time under provisional suspension counts against the ban—it is part of the procedure, not a gift.

The room where there was no doctor

I remember the summer of 2026, when Kolkata was printing six pages a day on the Russia World Cup and I was watching Hima Das's 400m final in Tampere. I understood then that the real athletics story is often in the room nobody visits. In Aga's case, that room is the medical room—or the one that should have existed.

Why did a 2:18–2:20 marathoner, who won the 2026 Tokyo Marathon and finished second at three World Marathon Majors, not have a registered team physician? Why did an athlete talking about more than a dozen race prizes not have a clean record of injury treatment?

This question connects to the day a 32-year-old marathoner had to get an injection in her knee. Chronic knee trouble is common in high-mileage marathon running. The pressure to mask pain is also common, because appearance fees and race contracts are tied to pain. Glucocorticoids are the cheapest, most available tool. And when there is no credentialed doctor nearby, the prescription comes from somewhere else—sometimes a fellow athlete, sometimes someone an agent knows, sometimes a family member who is "helping."

Aga's case shows that the crisis was not created by the drug but by the system that did not exist to manage it. With a registered doctor, a TUE application, a clean washout timeline—that March win in China would still be valid today.

When testing and careers collide on the same field

There is another angle to this case that gets less discussion: China's label-race circuit.

For East African marathoners, this circuit is a particular economic space—between Majors, low pressure, decent appearance fees, and races that are not too demanding. But the same circuit is now the AIU's highest-yield testing ground. The races that are attractive for money are now the most densely watched for testing. This collision swallowed names before Aga and will swallow names after her.

This is why the six-year ban will be read two ways. On one hand, it is the AIU's message that forging documents will cost more than taking a substance—which is technically correct. On the other, the question will arise whether six years for a glucocorticoid with no proven endurance benefit is disproportionate. For me, both things are true at once. The sanction is for tampering, not for the substance. But it is also true that if a European athlete had been in this case, she would have had a media and legal team from day one.

The slip that saved nothing

The bitterest part is that the biggest document of Aga's career—the 2026 Tokyo win—is not erased by this decision. Her 2026 performance remains what it was: a genuine, world-class marathoner. But a six-year ban at 32 means a return at 38—and in the depth of Ethiopian women's marathon running, there is no place for a 38-year-old with a doping record.

I often wonder: that March morning, in the mixed zone, if someone had asked her who was with her team—a doctor, a physio, an official—what would the answer have been? The answer to that question probably tells the whole story we are reading today. Next time an athlete smiles at the finish line, don't just look at the timer. Look at who is standing behind her. Because sometimes a six-year decision is made on the very day someone leaves a doctor's chair empty.

संबंधित खिलाड़ी